Keytruda

Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare
Investor Optimism Around Keytruda Drives Merck Stock To Golden Cross Ahead of Earnings
Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare
1 year ago
Investor Optimism Around Keytruda Drives Merck Stock To Golden Cross Ahead of Earnings
1 year ago
Merck Q2 Earnings Preview: Analyst Expectations, Jim Cramer's View, And The Spotlight On Keytruda
1 year ago
EXCLUSIVE: eFFECTOR Therapeutics Announces SPAC Deal To Advance Cancer-Fighting Pipeline
3 years ago

Keytruda Recent News

What Drove Merck's Keytruda Shortfall In Q4
Feb 24, 2020, 2:31 PM
|
What's Behind PDS Biotech's Rally?
Oct 3, 2019, 3:45 PM
|
Merck's Keytruda Gets A Double Dose Of Positive News
Jul 29, 2019, 1:30 PM
|
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
May 31, 2019, 5:45 PM
|
Merck's Keytruda Vs. Bristol-Myers Squibb's Opdivo In Q1 And Beyond
May 22, 2019, 4:38 PM
|
Iovance Issues Cancer Trial Updates Ahead Of ASCO Meeting, Sending Stock Skyward
May 16, 2019, 4:30 PM
|
Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates
Mar 29, 2019, 4:45 PM
|
Bristol-Myers Squibb Withdraws Regulatory Application For Lung Cancer Combo Drug
Jan 24, 2019, 2:35 PM
|
Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates
Dec 31, 2018, 2:00 PM
|
Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates
Nov 30, 2018, 6:09 PM
|
Merck Is Up 40% In 2018: What's Driving The Rally?
Nov 29, 2018, 9:11 PM
|
Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates
Nov 1, 2018, 1:26 PM
|
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
Jun 1, 2018, 5:22 PM
|
Merck, Bristol Myers Shares Move On Alleged FDA Alert On Keytruda
May 18, 2018, 3:33 PM
|
Incyte Falls 20% After Cancer Drug Fails Phase 3 Trial
Apr 6, 2018, 12:50 PM
|
Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates
Apr 3, 2018, 12:14 PM
|
Early Keytruda Results Win Merck An Upgrade
Jan 16, 2018, 6:19 PM
|
The Bull Thesis For Merck Is Evaporating
Oct 30, 2017, 3:14 PM
|
Analyst Grows Cautious On Merck's Keytruda
Oct 30, 2017, 2:08 PM
|
Boosted By Keytruda, Citi Upgrades Merck To Buy For The First Time Ever
Oct 18, 2017, 1:07 PM
|
Ahead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers
Jul 24, 2017, 7:29 PM
|
Tracking The Busy June PDUFA Calendar
May 30, 2017, 12:58 PM
|
The Most Notable Abstracts Released Ahead Of ASCO 2017
May 19, 2017, 12:21 PM
|

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved